Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amarantus Bioscience Holdings Inc (OP: AMBS )

0.0084 USD UNCHANGED
Streaming Delayed Price Updated: 1:35 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0084
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0084
Today's Range 0.0084 - 0.0084
52wk Range 0.0045 - 0.0235
Shares Outstanding 68,272,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health
From GlobeNewswire News Releases
Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARAs National Mobile CLIA Lab Partner Integrated Health
From NewMediaWire

Performance

YTD
-6.67%
-6.67%
1 Month
+20.00%
+20.00%
3 Month
+52.73%
+52.73%
6 Month
-21.50%
-21.50%
1 Year
-36.36%
-36.36%

More News

Read More
Todos Medical Enters into Exclusive Branding and Distribution Agreement with Melbourne Biotech for 96 and 384 Well RT-PCR Machines in the United States
From NewMediaWire
Todos Medical Enters into Exclusive Branding and Distribution Agreement with Melbourne Biotech for 96 and 384 Well RT-PCR Machines in the United States
From GlobeNewswire News Releases
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
From NewMediaWire
Todos Medical Enters Into COVID-19 PCR Testing Implementation and Equipment Financing Partnership with AID Genomics
From GlobeNewswire News Releases
Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million
From NewMediaWire
Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million
From GlobeNewswire News Releases
Todos Medical CEO Releases Letter to Shareholders
From NewMediaWire
Todos Medical CEO Releases Letter to Shareholders
From GlobeNewswire News Releases
3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma
From NewMediaWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.